OPKO Health Inc
XMUN:XCY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
OPKO Health Inc
XMUN:XCY
|
US |
|
N
|
National Vision Holdings Inc
SWB:7NV
|
US |
|
Prosus NV
AEX:PRX
|
NL |
|
Crocs Inc
NASDAQ:CROX
|
US |
|
R
|
RH
XMUN:RS1
|
US |
|
A
|
ALT Telecom PCL
SET:ALT
|
TH |
|
C
|
Crocs Inc
XMUN:C7N
|
US |
|
Yoshiharu Global Co
NASDAQ:VSTD
|
US |
|
P
|
PYC Therapeutics Ltd
F:PH7
|
AU |
|
Oxford Instruments PLC
F:OX3
|
UK |
|
S
|
Sempra
SWB:SE4
|
US |
|
Euronet Worldwide Inc
NASDAQ:EEFT
|
US |
|
G
|
Gap Inc
F:GAP
|
US |
|
O
|
Oracle Corp
F:ORC
|
US |
|
A
|
Advanced Micro Devices Inc
MIL:AMD
|
US |
|
O
|
Oracle Corp
XMUN:ORC
|
US |
|
E
|
Exotic Food PCL
SET:XO
|
TH |
|
S
|
Schneider Electric SE
DUS:SND
|
FR |
Wall St Price Targets
XCY Price Targets Summary
OPKO Health Inc
According to Wall Street analysts, the average 1-year price target for XCY is 3.9 EUR with a low forecast of 2.65 EUR and a high forecast of 7.81 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XCY's stock price target?
Price Target
3.9
EUR
According to Wall Street analysts, the average 1-year price target for XCY is 3.9 EUR with a low forecast of 2.65 EUR and a high forecast of 7.81 EUR.
What is the Revenue forecast for OPKO Health Inc?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 3 years is 0%.
What is the Gross Profit forecast for OPKO Health Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 3 years is 2%.
